Legend Biotech (LEGN) Gross Profit: 2018-2024
Historic Gross Profit for Legend Biotech (LEGN) over the last 7 years, with Dec 2024 value amounting to $410.9 million.
- Legend Biotech's Gross Profit rose 69.99% to $272.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $722.6 million, marking a year-over-year increase of 63.94%. This contributed to the annual value of $410.9 million for FY2024, which is 191.55% up from last year.
- According to the latest figures from FY2024, Legend Biotech's Gross Profit is $410.9 million, which was up 191.55% from $140.9 million recorded in FY2023.
- Legend Biotech's Gross Profit's 5-year high stood at $410.9 million during FY2024, with a 5-year trough of $51.6 million in FY2022.
- Its 3-year average for Gross Profit is $201.1 million, with a median of $140.9 million in 2023.
- Per our database at Business Quant, Legend Biotech's Gross Profit declined by 24.97% in 2022 and then spiked by 191.55% in 2024.
- Yearly analysis of 5 years shows Legend Biotech's Gross Profit stood at $75.0 million in 2020, then fell by 8.23% to $68.8 million in 2021, then declined by 24.97% to $51.6 million in 2022, then spiked by 172.90% to $140.9 million in 2023, then surged by 191.55% to $410.9 million in 2024.